Search result for 'tildrakizumab'

Sun Pharma introduces ILUMYA (Tildrakizumab) in India for moderate-to-severe plaque psoriasis treatment. A novel biologic with proven efficacy.

Sun Pharma's specialty product Ilumetri, indicated for psoriasis treatment, is now included in China's national reimbursement drug list, improving accessibility and affordability for patients.